Showing 40,061 - 40,080 results of 100,619 for search '(( 5 a decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (mean decrease)))) ))', query time: 1.61s Refine Results
  1. 40061

    Structure diagram of the DSC-SE module. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  2. 40062

    Configuration of the experimental environment. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  3. 40063

    Results of ablation experiments. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  4. 40064

    Performance comparison with other models. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  5. 40065

    Comparison of different methods. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  6. 40066

    Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma by Prabha Shrestha (776391)

    Published 2017
    “…Moreover, HIF-1α knockdown led to a decrease in the expression of various KSHV latent genes, including LANA, vCyclin, kaposin, and miRNAs, under both normoxic and hypoxic conditions. …”
  7. 40067
  8. 40068
  9. 40069
  10. 40070
  11. 40071
  12. 40072
  13. 40073
  14. 40074
  15. 40075
  16. 40076

    Image_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  17. 40077

    Table_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  18. 40078

    Image_3_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  19. 40079

    Image_2_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  20. 40080

    Image_4_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”